Non-coding RNAs (ncRNAs), once considered the 'dark matter' of the genome, have now emerged as pivotal regulators in cancer ...

Natural killer cells aren't just mindless defenders — a special type, adaptive NK cells, remember their enemies and come back ...

The American Association for Cancer Research’s annual conference continued Monday with Roche offering a postmortem for its ...

Some proteins in human cells that are implicated in cancer also have causal roles in neurodevelopmental disorders, raising ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...

Despite advancements in melanoma therapy, the prognosis remains unfavorable for many patients. The proteasome inhibitor MG132 has shown therapeutic potential through pathway regulation, yet its ...

1Oncology Drug Discovery Unit, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts. *Corresponding Author: Adnan O. Abu-Yousif, Oncology Drug ...

Letrozole to block estrogen, Kisqali to stop cancer cells from growing, and Zoladex to shut down my ovaries.” However, chemo is “not completely off the table,” she explained, saying ...